The surface of Chlamydia pneumoniae is covered with proteins but their exact identification is not known probably because of the presence of conformational epitopes. A family of 21 pmp genes has been found by DNA sequencing. In common, these genes have the capacity to encode the amino acid motif GGAI. Several of the genes have the capacity to encode outer membrane proteins of about 100 kDa. Thus, they are candidate genes to encode the protein(s) present in the 98-kDa protein band of the C. pneumoniae outer membrane complex. The production of recombinant GGAI proteins is described as is the use of polyclonal antibodies raised against the recombinant GGAI proteins to determine their expression in C. pneumoniae elementary bodies. At least three of the proteins, Omp4, 5, and 11, are expressed.
recombinant (r) proteins, we used Escherichia coli BL21(DE3) (NovaGene, La Jolla, CA).
Computer analyses. For computer analysis, we used Genetics Computer Group (GCG 8.1 and 9.1; Madison, WI) packages. Multiple alignment was performed with the PILEUP program. To search databases for sequences with the motif FxxNx (4, 14) GGA [ILV] , we used the FINDPATTERN program. Database search for protein homologs was done with the similarity search programs FASTA and BLAST (release 37) available at SWISSPROT (http://www.expasy.ch) and the GCG package. We did structural analyses with two programs: ProDom (update 23 July 1999; http://protein.toulouse.inra.fr/prodom.html) and PEP-TIDESTRUCTURE (GCG). The Fortran program AMPHI (1988 MPI Biology, Tuebingen, Germany) [20] was used for predicting the transmembrane b-strands. The program Compute pI/Mw (http: //www.expasy.ch/tools/pi_tool.html) [21] was used for determination of the isoelectric point and molecular weight (GenBank accession numbers: AJ001311, AJ133034, AJ133035, U72499, U65943, U65942, P45508, and Q03155).
Construction of rOmp4-hybrid protein. The recombinant hybrid protein between E. coli AIDA (Q03155) and C. pneumoniae Omp4 (AJ001311) was constructed by polymerase chain reaction (PCR) as described [11] . The upstream primer was constructed to encompass the pET30 LIC plasmid LIC sequence, two stop codons, and the E. coli Shine Delgarno sequence followed by 22 nucleotides of the omp4 sequence beginning with ATG (fMet). The omp4 downstream primer contained the omp4 sequence (aa 525-531) tailed by the AIDA b-barrel sequence (aa 839-848). To amplify the b-barrel part of E. coli AIDA, we used plasmid pIB264 (provided by M. Alexander Schmidt, Westfalische Wilhelms-University, Munster, Germany). The upstream primer was complementary to the tail of the omp4 downstream primer. The downstream E. coli AIDA primer encompassed the region downstream of the C-terminal part of the gene (3981-4005 bp; GenBank accession number, Q03155) tailed by a LIC site. Each primer set was used for PCR of C. pneumoniae and E. coli pIB264 DNA [15] . The two PCR products were mixed and amplified by two LIC primers. The hybrid gene thus obtained was cloned into the pET30 LIC vector (Novagen, Madison, WI) and transformed into E. coli NovaBlue. For expression, the plasmid was transformed into E. coli BL21 (DE3) after control sequencing. The hybrid protein thus consisted of Omp4 aa 1-531 and AIDA aa 839-1287.
Antibodies. Antibodies to C. pneumoniae OMC were obtained by purification of C. pneumoniae OMC [8] . Rabbits were immunized as described with purified C. pneumoniae OMC [11] , with or without solubilizing the proteins in SDS sample buffer before immunization (K151 to solubilized native OMC and K150 to SDSdenatured OMC). Recombinant proteins to the C. pneumoniae Omp4, 5, 6, 7, 9, 10, 11, 13, and 15 were obtained as fusion proteins from LIC cloning prepared as described [11] (K195, Omp4; K179, Omp5/K203; K204, Omp6; K207, Omp7; K208, Omp10; K201, Omp11; K202, Omp13; and K209, Omp15). Human serum samples were from healthy Danish blood donors.
Immunoblotting. Immunoblotting was performed as described [22] . Purified C. pneumoniae EBs were suspended in SDS sample buffer, loaded to a 10% SDS polyacrylamide gel, or boiled for 5 min before being loaded onto the gel to fully denature the proteins. The proteins were electrotransferred to nitrocellulose. Immunoblotting was done with K150 and K151 diluted 1:1000 or with human sera diluted 1:200. Antibody binding was detected with alkaline phosphatase-conjugated goat-anti human IgG (BioRad, Richmond, CA).
MIF microscopy. HEp-2 cells cultivated on coverslips were infected with 0.7 inclusion-forming units (ifu) per C. pneumoniae cell. After infection for 72 h, the infected monolayer was fixed with methanol for 1 h as described [19] . The infected monolayers were then incubated with primary antibodies diluted 1:50 for 30 min, washed, and incubated with fluorescein isothiocyanate-conjugated secondary antibodies (goat anti-rabbit IgG 1:100, Jackson ImmunoResearch Laboratories, West Grove, PA). MIF microscopy was done as described [19] .
Two-dimensional (2-D) PAGE and immunoblotting. 2-D PAGE was done as described [23] . Semiconfluent monolayers of HeLa cells were infected with 1 ifu per cell of C. pneumoniae VR1310. For detection of chlamydial protein synthesis, we used a methionine/cysteine-free RPMI 1640 medium containing 10 mg/mL gentamicin, 20 mg/mL cycloheximide, and 100 mCi/mL [ 35 S]methionine/cysteine (Promix; Amersham Laboratories, Amersham, UK). At the end of the labeling period, cells were washed in PBS, loosened with a rubber policeman in PBS, and (after centrifugation at 16,000 g for 30 min) resuspended in 30 mL of 10% SDS and boiled for 5 min. The sample was then resuspended in 1 mL of lysis buffer containing 9 M urea, 4% CHAPS, 40 mM Tris base, 65 mM dithioerythriol (DTE), and pharmalyte 3-10 (Pharmacia Biotech, Uppsala, Sweden) and sonicated and centrifuged at 16,000 g for 10 min. Supernatants containing the labeled chlamydial proteins were stored at Ϫ70ЊC until use.
For isoelectric focusing, we used 18-cm-long linear immobilized (pH 4-7) gradient drystrips (Pharmacia). Each strip was soaked overnight with unlabeled C. pneumoniae proteins with addition of an 35 S-labeled sample in lysis buffer in a reswelling tray (Pharmacia). The amount of 35 S-labeled chlamydial protein was adjusted to 200,000 cpm per strip. Rehydrated strips were run in the first dimension at 300, 350, 400, 450, and 500 V each for 0.5 h followed by 3500 V for 3 h and 5000 V for 20 h at 15ЊC. After the focusing was completed, the strips were equilibrated for 15 min in a buffer containing 6 M urea, 30% wt/vol glycerol, 2% wt/vol SDS, 0.05 M Tris-HCl, pH 6.8, and 2% wt/vol DTE. The strips were subsequently equilibrated in a buffer in which DTE was replaced by 2.5% wt/vol iodoacetamide. In the 2-D run, the proteins were separated on 9%-16% linear gradient SDS-polyacrylamide gels (18 mm) until the bromophenol blue front reached the cm ϫ 20cm ϫ 1 bottom of the gel.
Gels were soaked in deionized water and then equilibrated in a buffer containing 13 mM Tris, pH 7.2, 100 mM glycine, and 10% vol/vol methanol for 30 min. The polyvinylidene difluoride (PVDF) membranes (Immobilon-P; pore size 0.45-mm; Millipore, Bedford, UK) were soaked in methanol for 1 min and equilibrated as for the gels. After electroblotting, the membranes were immunostained as described [22] .
Electron microscopy (EM). EM was performed as described [24] . Recombinant E. coli Omp4 hybrid cells or plasmid-free E. coli cells, cultivated in Luria broth and induced with 1 mM isopropyl b-D-thiogalactopyranoside in the presence of 5 mM b-mercaptoethanol for 2 h, were mounted on carbon-coated, glow-discharged grids. After adsorption, immunodetection was done using the polyclonal antibody K151 (diluted 1:500) or patient serum samples (diluted 1:50). As secondary antibodies, we used goat antirabbit or goat anti-human conjugated with 15 nm of gold (BioCell, Cardiff, UK). EM was done with an electron microscope (Jeol 1010) equipped with a Kodak megaplus 1.4 slow scan camera. The image was transferred to a SUN SparcStation10 with an SDV digital video camera interface.
Results

GGAI gene family.
A homology search with the aa sequences of Omp4 and Omp5 [11] against the deduced openreading frames within the C. pneumoniae genome [12] revealed 21 genes with the potential to encode proteins. The predicted sizes and structures of these genes are shown in table 1. A characteristic of the hypothetical proteins was that they could be divided into two potential domains: an N-terminal domain consisting of a region with the motif GGAI present in a variable number and a C-terminal part. Ten GGAI genes were sequenced by our laboratory in parallel with the genome sequencing project (table 1) . omp4-15 genes were sequenced by our laboratory and the pmp1-21 genes were from the genome sequence [12] . Only one difference was found in the nucleotide sequences (at position 912 after the ATG in Omp5, there is a C residue less in the genome sequence than described by Knudsen et al. [11] ). This changes the open-reading frame to a premature stop in the genome sequence. Omp4, 5, and 10-14 were positioned in a cluster on the genome together with Pmp6 and Pmp15-18. In this cluster, all genes except Omp5 were in the same direction of transcription. Similarly, the Omp6-9 and 15 were localized in a cluster and all had the same direction of transcription. Finally, the genes encoding Pmp19 and 20 and the gene encoding Pmp21 were localized at different positions on the genome [12] .
As indicated in table 1, the DNA sequence of the genes showed they belonged to the GGAI gene family. Only 1 gene, omp13, had a truncated version of the gene with only 2 GGAI repeats. In 4 genes, omp8, omp9, omp15, and pmp17, frameshift mutations lead to a premature stop of the proteins in an otherwise full-length gene. Due to such a mutation, Omp8 did not contain the GGAI motif. The deduced aa sequence of omp/ pmp genes showed that 12 of the 21 genes had the capacity to encode proteins of very similar size (95.5-102 kDa) and 1, pmp6, could encode a protein of 143 kDa (table 1) . Alignment of the predicted aa sequence showed the over all aa sequence identity to be low. The alignment of Omp4, 5, 10, and 11 is shown in figure 1 . Patches of identical aas, of which the motif GGAI was repeated 6 times in the N-terminal part of the molecules, were scattered along the protein sequence. No particularly conserved parts could be identified. The alignment showed small gaps scattered along most of the sequence. The truncated omp13-and omp15-containing frameshift mutations differed from the aligned proteins by showing large insertions in the central part of the GGAI domain (data not shown). In the Cterminal part of the molecules, tryptophan residues were conserved, and in all cases where full-length molecules were predicted, the last aa was phenylalanine.
Analysis of GGAI protein structures. Two GGAI proteins (Omp4 and Omp5) were predicted to have a leader sequence with a cleavage site specific for signal peptidase II (at aa 15 and 17, respectively; figure 1) and are therefore potential lipoproteins [11] . Seventeen genes were predicted to have a leader sequence with a cleavage site specific for signal peptidase I (for Omp10 and 11 at aa 26); for 2 genes (pmp16 and 18), no such cleavage site was predicted. Thus, 19 of the 21 hypothetical proteins had the capacity to pass the chlamydial membrane.
To analyze for proteins with homology to the GGAI Chlamydia proteins, we searched databases using the FINDPAT-TERN program for proteins containing x GGAI (several times) or the motifs FxxN and GGA[ILV] separated by 4 to 14 nonconserved aa. The search revealed homology to membrane proteins of an additional 4 bacterial species. The proteins are the RompA protein of several Rickettsia species whose function is associated with adhesion, Bordetella pertussis adhesin FHAB, Helicobacter pylori HP1288, and E. coli Yfal proteins of unknown function. The search revealed 2 surface-exposed proteins but the mode by which the proteins were translocated to the surface was unknown.
To analyze for potential features that predict how GGAI could be incorporated into the chlamydial outer membrane, a computer analysis was performed. The Chou-Fassmann and Garnier-Osguthorpe-Robson predictions did not reveal any specific structures. We then analyzed the C-terminal part of the GGAI proteins by the computer program AMPHI. This pro- gram predicted that the C-terminal part of the GGAI proteins would produce a C-terminal transmembranic b-barrel consisting of 14 strands. A further indication that the GGAI proteins are transmembranic is that all contained conserved tryptophans and a phenylalanine residue as the most terminal aa and the presence of a potential amphipathic b-sheet with hydrophobic residues at positions 1, 3, 5, 7, and 9 from the C-terminal aa (figure 1) [25] . The presence of such a potential amphipathic b-sheet localized in the C-terminal part of the protein is characteristically present in outer membrane proteins of gram-negative bacteria [25] .
Expression of GGAI proteins. Expression of 9 GGAI proteins was studied by immunoblotting of SDS-PAGE-separated proteins from purified C. pneumoniae EBs reacted with hyperimmune serum from rabbits immunized with purified recombinant proteins (rOmp4-7, 9-11, 13, and 15). Results are shown in figure 2. Bands of 95-100 kDa were observed when antibodies to Omp4-7 and 9-11 were used (lanes numbered according to the rOmp proteins, respectively), while antibodies to Omp13 and 15 did not react. The 43-kDa band observed in lane 10 was also detected in serum obtained prior to immunization of the rabbit (results not shown). All bands seen in the immunoblots had the size expected from the deduced aa sequence except for the band in lane 9. According to the gene sequence, Omp9 contained a frameshift mutation leading to a premature stop at 59 kDa (table 1) . A band of this size was not observed. Instead reaction with a full-length protein was seen. This indicated that in some C. pneumoniae EBs, the mutation may be repaired, leading to a full-length protein. A different explanation for the anti-Omp9 antibody reaction could be that this antibody recognized a common epitope and thus could recognize different GGAI proteins as seen in C. psittaci [15] . The truncated Omp13 and 15 of 54 and 48 kDa, respectively, could not be detected by immunoblotting.
Expression of the GGAI proteins in C. pneumoniae-infected HEp-2 cells was further analyzed by MIF ( figure 3 ). Antibodies to Omp4-7 and 9-11 (see figure 3A) showed a bright fluorescence staining of the C. pneumoniae inclusions independent of their size, but anti-Omp13 and 15 antibodies did not react (figure 3B) . These results thus mirror those obtained by immunoblotting.
2-D PAGE and immunoblotting.
Of the 8t Omp proteins found to be expressed by immunoblotting and MIF, 7 were similar in size when analyzed by immunoblotting of SDS-PAGE-separated C. pneumoniae proteins. The pI of the GGAI proteins varied, however (table 1) . To further document which of the Omp proteins were expressed, 2-D PAGE and immunoblotting were performed. After separation on IPG strips and SDS-PAGE, the 35 S-labeled C. pneumoniae proteins were transferred to PVDF membranes and reacted with antibodies to the recombinant GGAI proteins. In figure 4A , the blot was reacted with anti-Omp4 antibodies. Strongly reacting spots were seen at the expected size and pI (arrows). To verify the localization of Omp4 at the C. pneumoniae proteome, an x-ray film was placed on top of the developed immunoblot membrane (figure 4B). The arrows indicate the position of the strongly reacting spots. In addition to the labeled Omp4 spots, tracks of spots over most of the 100-kDa pI 4-7 range could be seen. To compare the migration of C. pneumoniae Omp4 with rOmp4 synthesized in E. coli, 35 S-labeled rOmp4 was analyzed by 2D-PAGE ( figure 4C ). Spots migrating similarly to the C. pneumoniae Omp4 are marked with arrows. Addition of 35 Slabeled rOmp4 to the C. pneumoniae proteins revealed that the recombinant spots co-localized with those identified by immunoblotting ( figure 4D, arrows) . By similar analyses, it was possible to identify the expression and localization of Omp5 and Omp11. It was characteristic of the reaction pattern that each antibody recognized a track of spots of identical size and localized within a narrow pI range. Also, in E. coli, rOmp4 was expressed as a track of spots ( figure 4C ). This reaction pattern was similar to that found when monoclonal antibodies directed against the C. psittaci putative (P) OMP proteins that are homologous to the Omp/Pmp proteins of C. pneumoniae were analyzed by 2-D PAGE and immunoblotting [26] . Antibodies to rOmp6, 7, and 10 each recognized several tracks of spots, indicating the potential presence of a common epitope in agreement with that observed for C. psittaci POMP proteins [26] . The 35 S-labeled proteins seen in figure 4B indicated that many of the GGAI proteins of about 100 kDa may be expressed. Determination of the peptide content in each spot by mass spectroscopy analysis will identify their exact origin [27] .
Characterization and reaction of patient sera compared with reaction of K151 and K150 in immunoblotting. After determining the expression of several GGAI proteins, we attempted to learn whether they were recognized by the human humoral immune response. C. pneumoniae-seropositive sera do not show strong reactivity in immunoblotting [10, 28] and react variably with a 98-kDa protein band [10, 28] . Also, Omp4 and 5 migrate differently in SDS-PAGE with or without boiling of samples prior to electrophoretic separation of the proteins and this changes the reactivity with antibodies [11] . To determine this migration, antibodies obtained by immunizing rabbits with C. pneumoniae OMC with or without SDS denaturation of the antigen prior to immunization (K150 and K151, respectively) were used in immunoblotting of C. pneumoniae EB proteins. In figure 5A , K150 raised against SDS-denatured C. pneumoniae OMC is shown to react with the predicted bands of MOMP, Omp2, and the 98-kDa doublet (lane 2). With no boiling of the C. pneumoniae EB proteins before separation by SDS-PAGE, MOMP and Omp2 did not enter the gel when probed with monospecific antibody (data not shown), and the 98-kDa protein bands migrated more slowly as previously described [11] . K151 only reacted with the more slowly migrating bands (figure 5B). Immunoblotting of C. pneumoniae EB with patient sera showed no specific major immunogen [10, 28] but 53-, 60-, and 98-kDa bands were frequent.
Since K151 reacted differently than K150 in immunoblotting and differently regardless of whether the samples were boiled before SDS-PAGE (figure 5), we wondered if C. pneumoniae-positive patient sera would react similarly. Results are shown in figure 6 . The 6 sera from C. pneumoniae MIF-positive patients had a fairly uniform reaction pattern (figure 6A) compared with samples boiled before SDS-PAGE (figure 6B) where individual sera had different reaction patterns as previously described [10, 28] . For control, 3 negative sera were included (lanes 7-9). They reacted weakly with MOMP and the 98-kDa protein bands. Thus, in immunoblotting of C. pneumoniae proteins prepared without boiling before separation by SDS-PAGE, patient sera recognized a pattern of bands with migration similar to that observed with K150 ( figure 6A, lane 10) . This reaction may indicate but not prove that Omp proteins are recognized by the C. pneumoniae-positive human sera and that the epitopes are destroyed by boiling of the samples prior to separation of the proteins by SDS-PAGE.
EM. The immunoblotting results indicate a possible correlation between MIF-reacting proteins and the unboiled (and thus not completely unfolded) proteins seen in figures 5 and 6. Since patient sera did not react with purified recombinant GGAI proteins (data not shown), it was thought that these proteins did not fold correctly when produced in E. coli. In an effort to produce correctly folded recombinant GGAI proteins, we constructed a hybrid protein between a known b-barrel-forming protein (AIDA) from E. coli [29] and the GGAI part from Omp4. The protein was stably expressed upon induction in E. coli and reacted in immunoblotting with the antiOmp4 antibody (data not shown). To analyze whether the hybrid protein was transported to the surface of E. coli, immuno EM with K151 was done. The reaction is shown in figure 7A and the control, the same plasmid-free E. coli, in figure 7B . There was no surface labeling in the control, whereas the surface of the recombinant E. coli expressing the hybrid protein was uniformly labeled by immunogold, indicating that the N-terminal part of Omp4 was exported to the surface of E. coli where it reestablished the natively folded form. Similar results were obtained with patient sera ( figure 7C and 7D) . These results may be of importance for further understanding of the correctly folded structure of the C. pneumoniae outer membrane proteins.
Discussion
In this study, we demonstrated that at least 3 of the GGAI proteins, Omp4, Omp5, and Omp11, were expressed during cultivation of C. pneumoniae in HeLa and HEp-2 cells. Three gene products could be identified by 2-D PAGE and immunoblotting. By immunoblotting and immunofluorescence analysis of C. pneumoniae-infected HEp-2 cells, we found that 2 proteins were not expressed: the truncated gene product of omp13 and omp15 containing a frameshift mutation in the cen- 1-9) . Serum samples 1-6 were positive by microimmunofluoresence; 7-9 were negative. In lane 10, strips were reacted with K150 antibodies diluted 1:1000.
to identify individual spots and to overlay the spots obtained from recombinant GGAI proteins produced in E. coli. It was unexpected that both the immunoblots and radioactive labeling of the recombinant proteins showed tracks of spots. Such tracks may indicate the presence of posttranslational modifications. The findings are in agreement with those described by Giannikopoulou et al. [26] , who showed a similar reaction pattern of the Pomp proteins in C. psittaci. Their findings support the results we describe. Even though the potential posttranslational modifications have not yet been determined, Giannikopoulou et al. [26] suggested by use of the Pro-site program that since signatures for glycosylation and phosphorylation were present in all the C. psittaci pomp genes that the proteins could be posttranslationally modified. Since the proteins did not change size (as observed within the resolution of the proteome map), it is predominantly the charge and not the mass of the protein that is changed and thus only modifications involving charge changes may have occurred. Many spots were seen in the region around 100 kDa. Identification of each spot will be revealed by mass spectrometry [27] , which will unambiguously determine their identity.
Serodiagnosis of C. pneumoniae infections have mostly been done with the MIF technique. To replace this assay with an automated ELISA requires that correctly folded epitopes are present for the antibodies. Since no antibody-binding protein on the C. pneumoniae surface has been identified, a useful antigen has not yet been obtained and efforts using recombinant proteins have so far been unsuccessful (unpublished data). Since the recombinant Omp proteins did not react with seropositive patient sera, a different approach was taken. The use of the Nterminal part of the GGAI proteins fused with the C-terminal part of a known E. coli outer membrane protein, the b-barrel-forming protein AIDA [29] , and use of this transporter protein to carry the N-terminal part of the C. pneumoniae Omp4 to the surface of E. coli enabled us to test whether the Nterminal part of Omp4 could be recognized by antibodies. This was the case as shown in figure 7 . Identification of the Nterminal part of the GGAI protein to be recognized by the antibodies is in agreement with the results of Longbottom et al. [18] who, by immuno EM analysis with antibodies against the GGAI family member OMP90A from C. psittaci, demonstrated that only the N-terminal part of the protein is surface exposed.
With the demonstration of several expressed C. pneumoniae GGAI proteins and the recombinant hybrid protein technique presented here, it may be possible to use this knowledge to produce an antigen useful in ELISA. By dissecting the antigens recognized by the human humoral immune response it thus may be possible to identify immunogenic proteins. This knowledge can then be used in the search for protective antigens.
The requirement for a vaccine is to be able to mediate protection against infections. For C. pneumoniae infections, no such components have been identified. In a mouse model, we showed that both Omp4 and Omp5 are expressed in C. pneumoniae inclusions in bronchial epithelial cells [30] . Whether immunity to such infections may be obtained by vaccinating the mice with the recombinant GGAI proteins remains to be determined. It is, however, encouraging that it now seems possible to obtain natively folded surface-exposed recombinant C. pneumoniae outer membrane protein epitopes, thereby having a new tool for analysis of the structure and composition of the C. pneumoniae surface.
